Korean Market
OWNR
Choong Ang Vaccine Laboratory
★

Report on Ownership of Specific Securities by Executives and Major Shareholders with No Changes

 
OWNR
Choong Ang Vaccine Laboratory
★

Submission of Report on Ownership of Specific Securities (No Specific Content)

 
PERI
Choong Ang Vaccine Laboratory
★★★★

CAVAC Q1 2026 Net Profit Surges 57%, Boosts Shareholder Returns via Buyback and Dividend

 
EXCH
Choong Ang Vaccine Laboratory
★★★

2026 Q1 Operating Profit Surges 161.9%, Net Income Up 57.6%